Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON30922Phase 3Not yet recruiting
Phase 3, open-label trial of remifentanil, ropivacaine and sufentanil in labor pain (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Quality of pain relief, Patient satisfaction and 1 more. Planned start May 2007; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON30922.